Skip to content

Coffee consumption linked to reduced liver fibrosis in people with HBV, HCV and NAFLD

Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction

Liver fibrosis improves after successful treatment for hepatitis C

Liver cancer risk will remain elevated for people with cirrhosis cured of hepatitis C

Fatty liver may contribute to higher risk of death for HIV/HCV co-infected people

Cirrhosis and decompensation are common among people with chronic hepatitis C

Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection

Laurence Brunet at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

People with HIV and HCV co-infection who have fibrosis stages F2 and above should be prioritised for new anti-HCV therapies

Liver transplants in HIV/HCV co-infection: study underlines importance of hepatitis C treatment